FDA Approval Summary: Ado-Trastuzumab Emtansine for the Adjuvant Treatment of HER2-positive Early Breast CancerSuparna Wedam, Julia A. Beaver, Shenghui Tang et al.|Clinical Cancer Research|2020Cited by 92
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious <i>BRCA</i>-Mutated Metastatic Castrate-Resistant Prostate CancerMitchell S. Anscher, Julia A. Beaver, Elaine Chang et al.|The Oncologist|2020Cited by 74